IPad test could revolutionize dementia detection in underserved communities

NCT ID NCT05607732

Ongoing Diagnosis Sponsor: Northwestern University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This large study tests whether a simple iPad-based cognitive test, called MyCog, can help primary care doctors detect early dementia and cognitive impairment in underserved communities. Over 57,000 older adults from 24 clinics will take the test during routine visits. The goal is to see if this approach leads to more diagnoses and referrals compared to usual care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: iPad-based cognitive test (MyCog)
What this could lead to: If successful, this could provide a simple, scalable way for primary care doctors to catch cognitive decline early, especially in communities that often miss out on timely diagnosis.
What could go wrong: This is a pragmatic trial testing a screening tool, not a treatment. It may not improve patient outcomes, and early detection could cause anxiety or lead to unnecessary tests.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE COGNITIVE DECLINE COGNITIVE IMPAIRMENT DEMENTIA

Contacts and locations

Locations

Oak Street Health

Chicago, Illinois, 60617, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.